Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Morgan Stanley to...

    Morgan Stanley to invest Rs 145 crore in Manipal Health Enterprise

    GarimaWritten by Garima Published On 2019-05-17T09:45:00+05:30  |  Updated On 17 May 2019 9:45 AM IST
    Morgan Stanley to invest Rs 145 crore in Manipal Health Enterprise

    Manipal Health Enterprises Pvt Ltd is backed by private equity majors including Singapore's Temasek and TPG.


    Mumbai: Morgan Stanley India Infrastructure (MSII) Wednesday committed a Rs 145 crore investment in Manipal Health Enterprise, the healthcare arm of Manipal Education and Medical Group, for an undisclosed stake.


    The tie-up involves an investment of Rs 100 crore in Healthmap, a Public Private Partnership for diagnostic imaging in Indian healthcare, a statement said.


    Also Read: Temasek eyes to acquire 18 per cent stake in Manipal Healthcare




    "Healthmap has been at the forefront of making quality diagnostic imaging available to the masses and we are proud to play a role in advancing affordable healthcare in India," Dilip Jose, the Managing Director and Chief Executive of Manipal Health Enterprises said.


    He added millions are pushed deeper into poverty each year because of healthcare emergencies and costs and early diagnostic imaging can help them avoid such emergencies but the cost of the tests can be a deterrent.


    MHEPL is backed by private equity majors including Singapore's Temasek and TPG.


    Also Read: Major Investor In Manipal Healthcare now looking for Exit: Report




    diagnostic imagingFortis HealthcareHealthcarehealthcare armKarnatakaManipalManipal FoundationManipal GroupManipal HealthManipal Health EnterprisesMorgan Stanleyquality diagnostic imagingSikkim Manipal Universitystates and union territories of indiaTemasekUniversities and colleges in India
    Source : Bloomberg

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok